Pharmaceutical Product Development, a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services, has expanded its GMP (good manufacturing practices) analytical laboratory in Middleton, Wisconsin, USA.
PPD Laboratories’ new GMP analytical laboratory supplements the company’s existing biologics capacity and was constructed specifically for the stability and quality control testing of large molecule drug products.
With space for more than 100 new employees, the lab was designed with efficiency in mind, containing specialized areas dedicated to particular types of assays and scientific instrumentation unique to biologics. The facility has met GMP regulatory requirements, has been released for use and is already supporting new client projects.
The Middleton campus expansion also includes the renovation of PPD’s existing cell lab, which will double the capacity for GMP cell-based assays. The expanded laboratory will support a total of 70 cellular and molecular biology scientists upon its completion in mid-2018.
PPD Laboratories’ GMP lab is a leading provider of chemistry, manufacturing and controls (CMC) laboratory services for all phases of drug development. In addition to the GMP lab in Middleton, PPD Laboratories has a GMP lab in Athlone, Ireland, to meet the CMC testing needs of the European market. PPD Laboratories’ operations also include: a bioanalytical lab in Middleton; vaccine sciences, bioanalytical and biomarker labs in Richmond, Virginia; central labs in Shanghai, China; Brussels, Belgium; Highland Heights, Kentucky; and Singapore; and a biomarker lab in Highland Heights.